Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-000185
Filing Date
2018-02-05
Accepted
2018-02-05 16:54:04
Documents
1
Period of Report
2018-02-02

Document Format Files

Seq Description Document Type Size
1 form4-02052018_010248.html 4  
1 form4-02052018_010248.xml 4 4014
  Complete submission text file 0001415889-18-000185.txt   5476
Mailing Address FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076
Business Address
SAXE JON S (Reporting) CIK: 0001114914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 18574910

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations